279 related articles for article (PubMed ID: 30585173)
1. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
2. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo.
Dubiella C; Pinch BJ; Koikawa K; Zaidman D; Poon E; Manz TD; Nabet B; He S; Resnick E; Rogel A; Langer EM; Daniel CJ; Seo HS; Chen Y; Adelmant G; Sharifzadeh S; Ficarro SB; Jamin Y; Martins da Costa B; Zimmerman MW; Lian X; Kibe S; Kozono S; Doctor ZM; Browne CM; Yang A; Stoler-Barak L; Shah RB; Vangos NE; Geffken EA; Oren R; Koide E; Sidi S; Shulman Z; Wang C; Marto JA; Dhe-Paganon S; Look T; Zhou XZ; Lu KP; Sears RC; Chesler L; Gray NS; London N
Nat Chem Biol; 2021 Sep; 17(9):954-963. PubMed ID: 33972797
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
Zhao H; Cui G; Jin J; Chen X; Xu B
Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
[TBL] [Abstract][Full Text] [Related]
4. Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1).
Liu L; Zhu R; Li J; Pei Y; Wang S; Xu P; Wang M; Wen Y; Zhang H; Du D; Ding H; Jiang H; Chen K; Zhou B; Yu L; Luo C
J Med Chem; 2022 Feb; 65(3):2174-2190. PubMed ID: 35089030
[TBL] [Abstract][Full Text] [Related]
5. Dual Roles of Pin1 in Cancer Development and Progression.
Han HJ; Choi BY; Surh YJ
Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
[TBL] [Abstract][Full Text] [Related]
6. Identification of a potent and selective covalent Pin1 inhibitor.
Pinch BJ; Doctor ZM; Nabet B; Browne CM; Seo HS; Mohardt ML; Kozono S; Lian X; Manz TD; Chun Y; Kibe S; Zaidman D; Daitchman D; Yeoh ZC; Vangos NE; Geffken EA; Tan L; Ficarro SB; London N; Marto JA; Buratowski S; Dhe-Paganon S; Zhou XZ; Lu KP; Gray NS
Nat Chem Biol; 2020 Sep; 16(9):979-987. PubMed ID: 32483379
[TBL] [Abstract][Full Text] [Related]
7. Recent advances of Pin1 inhibitors as potential anticancer agents.
Bai Y; Yuan Z; Yuan S; He Z
Bioorg Chem; 2024 Mar; 144():107171. PubMed ID: 38325131
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
Du L; Wang X; Cui G; Xu B
Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Prenylated Flavonol Derivative as a Pin1 Inhibitor to Suppress Hepatocellular Carcinoma by Modulating MicroRNA Biogenesis.
Zheng Y; Pu W; Li J; Shen X; Zhou Q; Fan X; Yang SY; Yu Y; Chen Q; Wang C; Wu X; Peng Y
Chem Asian J; 2019 Jan; 14(1):130-134. PubMed ID: 30474357
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.
Cui G; Jin J; Chen H; Cao R; Chen X; Xu B
Bioorg Med Chem; 2018 May; 26(8):2186-2197. PubMed ID: 29576270
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesis.
Fan X; He H; Li J; Luo G; Zheng Y; Zhou JK; He J; Pu W; Zhao Y
Bioorg Med Chem; 2019 Jun; 27(11):2235-2244. PubMed ID: 31027708
[TBL] [Abstract][Full Text] [Related]
12. The role of Pin1 in the development and treatment of cancer.
Min SH; Zhou XZ; Lu KP
Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
[TBL] [Abstract][Full Text] [Related]
13. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
Cho JH; Chae JI; Shim JH
Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.
Ma T; Huang M; Li A; Zhao F; Li D; Liu D; Zhao L
Bioorg Med Chem Lett; 2019 Jul; 29(14):1859-1863. PubMed ID: 31103446
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.
Xu M; Cheung CC; Chow C; Lun SW; Cheung ST; Lo KW
PLoS One; 2016; 11(6):e0156833. PubMed ID: 27258148
[TBL] [Abstract][Full Text] [Related]
16. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L
Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831
[TBL] [Abstract][Full Text] [Related]
17. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
[TBL] [Abstract][Full Text] [Related]
18. Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors.
da Costa KS; Galúcio JM; de Jesus DA; Gomes GC; Lima E Lima AH; Taube PS; Dos Santos AM; Lameira J
Curr Comput Aided Drug Des; 2020; 16(5):605-617. PubMed ID: 31654518
[TBL] [Abstract][Full Text] [Related]
19. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
[TBL] [Abstract][Full Text] [Related]
20. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
